Healthcare & Life Sciences

Cambridge Cognition

aliveseries-c-plus
series-c-plus
Stage
1
Investors

About

Cambridge Cognition develops scientifically validated digital cognitive assessments and neuroscience technology platforms used in clinical research, drug development, and healthcare to measure brain health and cognitive function.

Explore Cambridge Cognition's full profile on Brouky

Funding rounds, investor list, and risk signals — unlock with a subscription.